Literature DB >> 20513428

The Skp2 promoter integrates signaling through the NF-kappaB, p53, and Akt/GSK3beta pathways to regulate autophagy and apoptosis.

Benjamin Barré1, Neil D Perkins.   

Abstract

NF-kappaB and p53 are important regulators of the cellular response to stress. Here, we identify the Skp2 gene as being both an NF-kappaB and p53 target after DNA damage. However, Skp2 expression can be either induced or repressed in a manner requiring both the p52 NF-kappaB subunit and p53, with subsequent effects on autophagy, apoptosis, and p53 function. This process is regulated by the Akt(PKB)/GSK3beta pathway. When Akt is active, GSK3beta is repressed, allowing p52 and p53 to cooperatively induce Skp2 expression. However, if Akt is inactive, GSK3beta phosphorylates p52 at Ser 222. This modification disrupts p52 homodimer/Bcl-3 complexes and facilitates transcriptional repression by p52/-c-Rel. The Skp2 promoter therefore integrates signaling through the NF-kappaB, p53, and Akt/GSK3beta pathways to regulate cell fate in response to DNA damage. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20513428     DOI: 10.1016/j.molcel.2010.03.018

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  37 in total

1.  p63 maintains keratinocyte proliferative capacity through regulation of Skp2-p130 levels.

Authors:  Simon S McDade; Daksha Patel; Dennis J McCance
Journal:  J Cell Sci       Date:  2011-04-21       Impact factor: 5.285

2.  Two polymorphic residues account for the differences in DNA binding and transcriptional activation by NF-κB proteins encoded by naturally occurring alleles in Nematostella vectensis.

Authors:  Francis S Wolenski; Sushil Chandani; Derek J Stefanik; Ning Jiang; Emma Chu; John R Finnerty; Thomas D Gilmore
Journal:  J Mol Evol       Date:  2011-12-25       Impact factor: 2.395

3.  PIASy-mediated Tip60 sumoylation regulates p53-induced autophagy.

Authors:  Samisubbu R Naidu; Alexander J Lakhter; Elliot J Androphy
Journal:  Cell Cycle       Date:  2012-07-15       Impact factor: 4.534

Review 4.  Nuclear initiated NF-κB signaling: NEMO and ATM take center stage.

Authors:  Shigeki Miyamoto
Journal:  Cell Res       Date:  2010-12-28       Impact factor: 25.617

5.  Adhesion-dependent Skp2 transcription requires selenocysteine tRNA gene transcription-activating factor (STAF).

Authors:  Ivette Hernández-Negrete; Graciela B Sala-Newby; Andras Perl; Gary R Kunkel; Andrew C Newby; Mark Bond
Journal:  Biochem J       Date:  2011-05-15       Impact factor: 3.857

6.  Tissue-specific apoptotic effects of the p53 codon 72 polymorphism in a mouse model.

Authors:  Gregory A Azzam; Amanda K Frank; Monica Hollstein; Maureen E Murphy
Journal:  Cell Cycle       Date:  2011-05-01       Impact factor: 4.534

7.  Intranasal Administration of GDNF Protects Against Neural Apoptosis in a Rat Model of Parkinson's Disease Through PI3K/Akt/GSK3β Pathway.

Authors:  Peijian Yue; Lin Gao; Xuejing Wang; Xuebing Ding; Junfang Teng
Journal:  Neurochem Res       Date:  2017-02-28       Impact factor: 3.996

8.  Adenosine monophosphate-activated protein kinase-α2 deficiency promotes vascular smooth muscle cell migration via S-phase kinase-associated protein 2 upregulation and E-cadherin downregulation.

Authors:  Ping Song; Yanhong Zhou; Kathleen A Coughlan; Xiaoyan Dai; Hairong Xu; Benoit Viollet; Ming-Hui Zou
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-10-10       Impact factor: 8.311

Review 9.  Emerging roles of p53 and other tumour-suppressor genes in immune regulation.

Authors:  César Muñoz-Fontela; Anna Mandinova; Stuart A Aaronson; Sam W Lee
Journal:  Nat Rev Immunol       Date:  2016-09-26       Impact factor: 53.106

10.  pRb/E2F-1-mediated caspase-dependent induction of Noxa amplifies the apoptotic effects of the Bcl-2/Bcl-xL inhibitor ABT-737.

Authors:  J Bertin-Ciftci; B Barré; J Le Pen; L Maillet; C Couriaud; P Juin; F Braun
Journal:  Cell Death Differ       Date:  2013-02-22       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.